Option chain shows key data for Interpace Biosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Interpace Biosciences.

Interpace Biosciences (OTC:IDXG) Stock, Option Chain

Interpace Diagnostics Gr

Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features. The company develops and commercializes genomic tests and related first-line assays that can personalize medicine and help improve patient diagnosis and management. Its clinical customers mainly consist of physicians, hospitals, cancer centers, commercial laboratories, pathology groups, and clinics. The various diagnostic tests offered by the company include ThyGeNEXT and ThyraMIRv2 for the detection of thyroid cancer, PancraGEN for pancreatic and biliary cancer, RespriDx for lung cancer, and BarreGEN for the detection of esophageal cancer.

Interpace Biosciences

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACIC

AEHL

AEZS

AGFY

AHAC

AIKI

AKER

ALJJ

ANPC

ANTE

ANVS

ATEX

BLCT

CFAC

CHNR

CLPS

CNET

CSOD

CTRM

CTXR

DNMR

DOGZ

DOYU

EARS

EBON

EDRY

ELYS

ESEA

EVFM

FLDM

FNHC

GLBS

GRNQ

GSKY

GTY Technology Holdings, Inc. - Class A Ordinary Shares

GTYH

HIHO

HOTH

IBIO

IDXG

IMUX

IMVT

IPDN

KRNT

LKCO

LODE

MOGO

MOSY

MVIS

ONCY

PBTS

PCSA

PETZ

PHCF

PLIN

POWW

RCON

RELI

RIOT

SCKT

SHIP

SIFY

SNDL

TIRX

TMBR

TOPS

TRCH

TRXC

TUSK

TYHT

VOXX

WING

92 Biggest Movers From Yesterday

Intraday Update

ABEO

AMPG

ANCN

ANDE

ARTW

WTER

Gainers


	TDH Holdings, Inc. (NASDAQ: PETZ) shares climbed 302% to $12.58 after jumping more than 25% on Tuesday.


70 Stocks Moving In Wednesday&#39;s Mid-Day Session

Short Sellers

APVO

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATIF

AVCT

AVYA

AXAS

BYSI

CBAT

CIIC

CLLS

FCEL

FRAN

FTSI

GLSI

HCCH

JMIA

KNDI

KZIA

LMNL

MDLY

MFGP

MGEN

NAKD

NCLH

NETE

NKLA

NXTD

ONCT

PAYS

PRPH

PXLW

Lordstown Motors Corp. - Class A Common Stock

RIDE

RMED

SNOA

SYNL

VERI

WTRH

Gainers


	Phoenix Tree Holdings Limited (NYSE: DNK) shares jumped 90.4% to close at $4.57 on Wednesday after jumping around 75%on Tuesday.


60 Biggest Movers From Yesterday

INTERPACE BIOSCIENCES INC by Interpace Biosciences, Inc.

Interpace Biosciences Inc

Press Releases

Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract

Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts

Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results

Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq

Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results

Effective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

PancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring Plan

Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business Results

Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer Risk

Interpace Biosciences Announces First Quarter 2025 Financial and Business Results

Comments

Interpace Biosciences

Interpace Biosciences (IDXG) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell